financetom
Business
financetom
/
Business
/
Abercrombie & Fitch Insider Sold Shares Worth $459,200, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Abercrombie & Fitch Insider Sold Shares Worth $459,200, According to a Recent SEC Filing
Dec 5, 2024 2:40 PM

05:21 PM EST, 12/05/2024 (MT Newswires) -- Suzanne M Coulter, Director, on December 04, 2024, sold 2,870 shares in Abercrombie & Fitch ( ANF ) for $459,200. Following the Form 4 filing with the SEC, Coulter has control over a total of 6,405 shares of the company, with 6,405 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1018840/000122520824010583/xslF345X05/doc4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US court blocks Kroger's $25 billion acquisition of grocery rival Albertsons
US court blocks Kroger's $25 billion acquisition of grocery rival Albertsons
Dec 10, 2024
Dec 10 (Reuters) - A U.S. judge blocked the pending $25 billion merger of U.S. grocery chains Kroger ( KR ) and Albertsons ( ACI ) on Tuesday, siding with the U.S. Federal Trade Commission in a win for the Biden administration. The FTC argued at a three-week trial in Portland, Oregon, that the merger would eliminate head-to-head competition between...
Jazz Pharmaceuticals Likely to Launch FDA-Approved Biliary Tract Cancer Treatment in 2025, RBC Says
Jazz Pharmaceuticals Likely to Launch FDA-Approved Biliary Tract Cancer Treatment in 2025, RBC Says
Dec 10, 2024
03:32 PM EST, 12/10/2024 (MT Newswires) -- Jazz Pharmaceuticals' ( JAZZ ) investor event on Wednesday is expected to set the stage for commercial launch possibly next year of its biliary tract cancer treatment Ziihera, RBC Capital Markets said in a note. The US Food and Drug Administration's accelerated approval of Ziihera brings Jazz a step closer towards new revenue...
US court blocks Kroger's $25 billion acquisition of grocery rival Albertsons
US court blocks Kroger's $25 billion acquisition of grocery rival Albertsons
Dec 10, 2024
(Reuters) - A U.S. judge blocked the pending $25 billion merger of U.S. grocery chains Kroger and Albertsons on Tuesday, siding with the U.S. Federal Trade Commission in a win for the Biden administration. The FTC argued at a three-week trial in Portland, Oregon, that the merger would eliminate head-to-head competition between the top two traditional grocery chains, leading to...
Siga's mpox drug did not improve lesion resolution or pain, NIH study finds
Siga's mpox drug did not improve lesion resolution or pain, NIH study finds
Dec 10, 2024
Dec 10 (Reuters) - Siga Technologies' ( SIGA ) antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults affected by the clade II strain of mpox, according to a National Institutes of Health study published on Tuesday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved